Treatment of severe atopic dermatitis with Tralokinumab in real clinical practice. Short-term effectiveness and safety results.

José-Juan Pereyra-RodriguezPedro HerranzRicardo Ruiz VillaverdeMarta Elosua-GonzálezManuel Galán-GutiérrezIgnasi Figueras-NartJavier MiquelPablo de la CuevaEsther Serra-BaldrichMonica Munera-CamposGemma Melé-NinotVicente Expósito-SerranoBibiana PerezAmalia SerranoJavier F Ortiz de FrutosJosé C Armario-Hita

Published in: Clinical and experimental dermatology (2023)

Patients, with a long history of disease and prior multidrug failure, showed a good response to Tralokinumab, confirming clinical trial results.

Keyphrases

clinical trial
atopic dermatitis
clinical practice
open label
drug resistant
combination therapy
double blind